278 related articles for article (PubMed ID: 22570487)
21. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan.
Dowling P; Lohan J; Ohlendieck K
Eur J Cell Biol; 2003 May; 82(5):222-30. PubMed ID: 12800977
[TBL] [Abstract][Full Text] [Related]
23. β1D chain increases α7β1 integrin and laminin and protects against sarcolemmal damage in mdx mice.
Liu J; Milner DJ; Boppart MD; Ross RS; Kaufman SJ
Hum Mol Genet; 2012 Apr; 21(7):1592-603. PubMed ID: 22180459
[TBL] [Abstract][Full Text] [Related]
24. Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx mice.
Tamma R; Annese T; Capogrosso RF; Cozzoli A; Benagiano V; Sblendorio V; Ruggieri S; Crivellato E; Specchia G; Ribatti D; De Luca A; Nico B
Lab Invest; 2013 May; 93(5):592-610. PubMed ID: 23528847
[TBL] [Abstract][Full Text] [Related]
25. Differentiation-related glycan epitopes identify discrete domains of the muscle glycocalyx.
McMorran BJ; McCarthy FE; Gibbs EM; Pang M; Marshall JL; Nairn AV; Moremen KW; Crosbie-Watson RH; Baum LG
Glycobiology; 2016 Oct; 26(10):1120-1132. PubMed ID: 27236198
[TBL] [Abstract][Full Text] [Related]
26. Defects in glycosylation impair satellite stem cell function and niche composition in the muscles of the dystrophic Large(myd) mouse.
Ross J; Benn A; Jonuschies J; Boldrin L; Muntoni F; Hewitt JE; Brown SC; Morgan JE
Stem Cells; 2012 Oct; 30(10):2330-41. PubMed ID: 22887880
[TBL] [Abstract][Full Text] [Related]
27. Sarcolemma instability during mechanical activity in Largemyd cardiac myocytes with loss of dystroglycan extracellular matrix receptor function.
Kabaeva Z; Meekhof KE; Michele DE
Hum Mol Genet; 2011 Sep; 20(17):3346-55. PubMed ID: 21628317
[TBL] [Abstract][Full Text] [Related]
28. Wisteria floribunda agglutinin staining for the quantitative assessment of cardiac fibrogenic activity in a mouse model of dilated cardiomyopathy.
Nagai-Okatani C; Nishigori M; Sato T; Minamino N; Kaji H; Kuno A
Lab Invest; 2019 Nov; 99(11):1749-1765. PubMed ID: 31253865
[TBL] [Abstract][Full Text] [Related]
29. High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy.
Shu C; Parfenova L; Mokhonova E; Collado JR; Damoiseaux R; Campagna J; John V; Crosbie RH
Skelet Muscle; 2020 Sep; 10(1):26. PubMed ID: 32948250
[TBL] [Abstract][Full Text] [Related]
30. Sarcolemmal targeting of nNOSμ improves contractile function of mdx muscle.
Rebolledo DL; Kim MJ; Whitehead NP; Adams ME; Froehner SC
Hum Mol Genet; 2016 Jan; 25(1):158-66. PubMed ID: 26604149
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice.
Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ
Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302
[TBL] [Abstract][Full Text] [Related]
32. Core 1 glycans on alpha-dystroglycan mediate laminin-induced acetylcholine receptor clustering but not laminin binding.
McDearmon EL; Combs AC; Ervasti JM
J Biol Chem; 2003 Nov; 278(45):44868-73. PubMed ID: 12952987
[TBL] [Abstract][Full Text] [Related]
33. Glycomic analyses of mouse models of congenital muscular dystrophy.
Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
[TBL] [Abstract][Full Text] [Related]
34. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
Elife; 2023 Feb; 12():. PubMed ID: 36723429
[TBL] [Abstract][Full Text] [Related]
35. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
[TBL] [Abstract][Full Text] [Related]
36. Wisteria floribunda agglutinin-binding glycan expression is decreased in endometriomata.
Hirakawa T; Nasu K; Kai K; Aoyagi Y; Ishii T; Uemura T; Yano M; Narahara H
Reprod Biol Endocrinol; 2014 Oct; 12():100. PubMed ID: 25344456
[TBL] [Abstract][Full Text] [Related]
37. Laminin-alpha1 globular domains 3 and 4 induce heterotrimeric G protein binding to alpha-syntrophin's PDZ domain and alter intracellular Ca2+ in muscle.
Zhou YW; Oak SA; Senogles SE; Jarrett HW
Am J Physiol Cell Physiol; 2005 Feb; 288(2):C377-88. PubMed ID: 15385269
[TBL] [Abstract][Full Text] [Related]
38. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
39. Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha 7B expression and caveolin-3 distribution.
Côté PD; Moukhles H; Carbonetto S
J Biol Chem; 2002 Feb; 277(7):4672-9. PubMed ID: 11741881
[TBL] [Abstract][Full Text] [Related]
40. Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy.
Warner LE; DelloRusso C; Crawford RW; Rybakova IN; Patel JR; Ervasti JM; Chamberlain JS
Hum Mol Genet; 2002 May; 11(9):1095-105. PubMed ID: 11978768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
